Company Update: Allergan Inc (NYSE:AGN) – Allergan Comments on Valeant Letter

[Business Wire] – Allergan, Inc. today issued the following statement in response to Valeant Pharmaceuticals International, Inc.’s October 27, 2 Read more on this. Allergan Inc. (AGN), valued at $54.54B, opened at . . . → Read More: Company Update: Allergan Inc (NYSE:AGN) – Allergan Comments on Valeant Letter Similar Articles: Market Update (NYSE:AGN): Allergan Issues Statement Regarding Recent Valeant Correspondence Market Update (NYSE:AGN): Pershing Square, Valeant and Allergan Settle Pending Litigation Before the Delaware Court of Chancery Company Update (NYSE:AGN): Allergan Provides Update on Written Requests from Pershing Square Regarding Special Meeting of Stockholders